Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGINTERFERON LAMBDA-1A: 70 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
70
Total FAERS Reports
10 (14.3%)
Deaths Reported
33
Hospitalizations
70
As Primary/Secondary Suspect
8
Life-Threatening

First Report: 20121112 · Latest Report: 20150101

What Are the Most Common PEGINTERFERON LAMBDA-1A Side Effects?

#1 Most Reported
Rash
18 reports (25.7%)
#2 Most Reported
Jaundice
18 reports (25.7%)
#3 Most Reported
Aspartate aminotransferase increased
8 reports (11.4%)

All PEGINTERFERON LAMBDA-1A Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Jaundice 18 25.7% 2 6
Rash 18 25.7% 5 11
Alanine aminotransferase increased 8 11.4% 0 2
Aspartate aminotransferase increased 8 11.4% 0 2
Hyperbilirubinaemia 7 10.0% 1 2
Pyrexia 7 10.0% 6 4
Ascites 6 8.6% 6 3
Haemoglobin decreased 6 8.6% 1 2
Hepatic failure 6 8.6% 6 3
Sleep disorder 6 8.6% 0 6
Affective disorder 5 7.1% 0 5
Cholestasis 5 7.1% 5 2
Dizziness 5 7.1% 0 5
Encephalopathy 5 7.1% 5 2
Epilepsy 5 7.1% 0 5
Feeling abnormal 5 7.1% 0 5
Gamma-glutamyltransferase increased 5 7.1% 0 2
Hyperthyroidism 5 7.1% 0 5
Influenza like illness 5 7.1% 0 5
Migraine 5 7.1% 0 5

Who Reports PEGINTERFERON LAMBDA-1A Side Effects? Age & Gender Data

Gender: 30.2% female, 69.8% male. Average age: 52.5 years. Most reports from: IT. View detailed demographics →

Is PEGINTERFERON LAMBDA-1A Getting Safer? Reports by Year

YearReportsDeathsHosp.
2012 3 0 1
2013 40 1 20
2014 15 8 7
2015 5 0 5

View full timeline →

What Is PEGINTERFERON LAMBDA-1A Used For?

IndicationReports
Chronic hepatitis c 60
Antiviral treatment 5
Hepatitis c 5

Official FDA Label for PEGINTERFERON LAMBDA-1A

Official prescribing information from the FDA-approved drug label.